Patent classifications
A61F2/88
HELICAL ULTRA LOW FORESHORTENING STENT
Various embodiments for an endovascular implantable device (and variations thereof) that virtually eliminates the problem of stent foreshortening phenomena in which the length of a stent or prosthesis shortens as the prosthesis is expanded in the biological vessel.
DEVICES, TREATMENTS AND METHODS TO RESTORE TISSUE ELASTIC RECOIL
Pulmonary treatment devices, systems and methods of use are provided which take into account the vast tissue damage of advanced COPD sufferers and provide treatments designed specifically to treat the particularly compromised lung tissues that are present in these patients. These treatments reduce trapped air volume, tension lung tissue and enhance lung elastic recoil. In particular, a variety of embodiments of invertible pulmonary treatment devices are provided. The devices are comprised of a shape memory material wherein the devices are able to be expanded under tension, and then are able to recoil back toward an original relaxed or resting shape. In these embodiments, a portion of the device is invertible. Thus, each device is able to store energy at least in the inversion, wherein the energy is utilized to continually tension the lung as the device relaxes toward its original shape.
STENT, STENT PRECURSOR PRODUCTION DEVICE, AND STENT PRODUCTION METHOD
In this stent, two superelastic fine wires are disposed along the axial direction at a prescribed helical pitch so as to have a prescribed stent inner diameter D0, while a pair is formed between two helical fine wires that are disposed across a micro gap of a size not more than five times the wire diameter of the fine wires in such a manner as to include a mutually contacting state. A prescribed reticulation gap is formed by crossing a clockwise-wound helical fine wire pair and a counterclockwise-wound helical fine wire pair in a plain-woven fashion, so as to have an axial gap equal to [(prescribed helical pitch)−{2×(fine wire diameter)}−(micro gap)] and a circumferential gap equal to [{(stent inner circumferential length corresponding to stent inner diameter)/N}−{2×(fine wire diameter)}−(micro gap
STENT, STENT PRECURSOR PRODUCTION DEVICE, AND STENT PRODUCTION METHOD
In this stent, two superelastic fine wires are disposed along the axial direction at a prescribed helical pitch so as to have a prescribed stent inner diameter D0, while a pair is formed between two helical fine wires that are disposed across a micro gap of a size not more than five times the wire diameter of the fine wires in such a manner as to include a mutually contacting state. A prescribed reticulation gap is formed by crossing a clockwise-wound helical fine wire pair and a counterclockwise-wound helical fine wire pair in a plain-woven fashion, so as to have an axial gap equal to [(prescribed helical pitch)−{2×(fine wire diameter)}−(micro gap)] and a circumferential gap equal to [{(stent inner circumferential length corresponding to stent inner diameter)/N}−{2×(fine wire diameter)}−(micro gap
SELF EXPANDING STENT AND METHOD OF LOADING SAME INTO A CATHETER
A stent comprises a framework that includes a sequence of cells that each occupy a discrete segment of the stent length, and each of the cells includes a plurality of struts with ends connected at respective vertices. An adjacent pair of the cells are attached to one another by a plurality of T-bars that each include a column defining a long axis that extends parallel to the stent axis, and a top bar attached to one end of the column. An opposite end of the column is attached to a first cell, and the top bar is attached at opposite ends to a second cell of the adjacent pair of cells. The column has a minimum width perpendicular to the long axis that is wider than a maximum width of each of the struts, and the column defines at least one slot. The top bar includes a curved edge on an opposite side from the column, and the curved edge straddles the long axis.
SELF EXPANDING STENT AND METHOD OF LOADING SAME INTO A CATHETER
A stent comprises a framework that includes a sequence of cells that each occupy a discrete segment of the stent length, and each of the cells includes a plurality of struts with ends connected at respective vertices. An adjacent pair of the cells are attached to one another by a plurality of T-bars that each include a column defining a long axis that extends parallel to the stent axis, and a top bar attached to one end of the column. An opposite end of the column is attached to a first cell, and the top bar is attached at opposite ends to a second cell of the adjacent pair of cells. The column has a minimum width perpendicular to the long axis that is wider than a maximum width of each of the struts, and the column defines at least one slot. The top bar includes a curved edge on an opposite side from the column, and the curved edge straddles the long axis.
LUMEN APPOSING STENT TO DELIVER TARGETED THERAPY
Devices, systems, and methods for delivering targeted therapy to tissue at a treatment site with the use of a stent. The targeted therapy may include a functional and/or therapeutic agent separate from the stent, or a component of a functional and/or therapeutic agent separate from the stent and reactive with another component of a functional and/or therapeutic agent on the stent. The agent or component of an agent may be delivered with the stent, and/or before delivery of the stent, and/or after the stent has been delivered.
LUMEN APPOSING STENT TO DELIVER TARGETED THERAPY
Devices, systems, and methods for delivering targeted therapy to tissue at a treatment site with the use of a stent. The targeted therapy may include a functional and/or therapeutic agent separate from the stent, or a component of a functional and/or therapeutic agent separate from the stent and reactive with another component of a functional and/or therapeutic agent on the stent. The agent or component of an agent may be delivered with the stent, and/or before delivery of the stent, and/or after the stent has been delivered.
Brain Aneurysm Manager
Brain Aneurysm Repair kit is a device developed to treat SAH (Sub-arachnoid Hemorrhage). It seals arterial damaged wall from ruptured brain aneurysms, stops the bleeding into the Sub-arachnoid space, and restores flow in the fastest way possible. Once the Cath is introduced, a dye is injected to identify the ruptured aneurysm site, a silicone-cover coated stent with a sticky adhesive on its out-surface is deployed, then the stent is inflated with a balloon against the ruptured arterial wall to stop the bleed, the sticky surface of the stent's silicone is secured against the arterial wall to close off the broken arterial wall and restore blood flow.
Brain Aneurysm Manager
Brain Aneurysm Repair kit is a device developed to treat SAH (Sub-arachnoid Hemorrhage). It seals arterial damaged wall from ruptured brain aneurysms, stops the bleeding into the Sub-arachnoid space, and restores flow in the fastest way possible. Once the Cath is introduced, a dye is injected to identify the ruptured aneurysm site, a silicone-cover coated stent with a sticky adhesive on its out-surface is deployed, then the stent is inflated with a balloon against the ruptured arterial wall to stop the bleed, the sticky surface of the stent's silicone is secured against the arterial wall to close off the broken arterial wall and restore blood flow.